Stada Bags European Rights from Alvotech to Biosimilar of Amgen Blockbusters

Published: Jun 11, 2024 By Nick Paul Taylor

Businessmen shaking hands/iStock

Pictured: Businessmen shaking hands after closing a deal/iStock, Tippapatt

Alvotech and Stada have expanded their alliance to include a clinical-stage biosimilar of Amgen’s blockbuster bone drugs Prolia…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks